rs61120041
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001429.4(EP300):c.730-18_730-9delTTTGTTTCTT variant causes a intron change. The variant allele was found at a frequency of 0.0122 in 1,611,928 control chromosomes in the GnomAD database, including 1,413 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.041 ( 419 hom., cov: 31)
Exomes 𝑓: 0.0091 ( 994 hom. )
Consequence
EP300
NM_001429.4 intron
NM_001429.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.05
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 22-41125844-CTTTTGTTTCT-C is Benign according to our data. Variant chr22-41125844-CTTTTGTTTCT-C is described in ClinVar as [Benign]. Clinvar id is 93745.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.196 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EP300 | NM_001429.4 | c.730-18_730-9delTTTGTTTCTT | intron_variant | ENST00000263253.9 | NP_001420.2 | |||
EP300 | NM_001362843.2 | c.730-18_730-9delTTTGTTTCTT | intron_variant | NP_001349772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EP300 | ENST00000263253.9 | c.730-18_730-9delTTTGTTTCTT | intron_variant | 1 | NM_001429.4 | ENSP00000263253.7 |
Frequencies
GnomAD3 genomes AF: 0.0410 AC: 6230AN: 152040Hom.: 418 Cov.: 31
GnomAD3 genomes
AF:
AC:
6230
AN:
152040
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0261 AC: 6543AN: 250674Hom.: 565 AF XY: 0.0225 AC XY: 3046AN XY: 135600
GnomAD3 exomes
AF:
AC:
6543
AN:
250674
Hom.:
AF XY:
AC XY:
3046
AN XY:
135600
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00915 AC: 13350AN: 1459770Hom.: 994 AF XY: 0.00878 AC XY: 6377AN XY: 726298
GnomAD4 exome
AF:
AC:
13350
AN:
1459770
Hom.:
AF XY:
AC XY:
6377
AN XY:
726298
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0410 AC: 6237AN: 152158Hom.: 419 Cov.: 31 AF XY: 0.0406 AC XY: 3019AN XY: 74392
GnomAD4 genome
AF:
AC:
6237
AN:
152158
Hom.:
Cov.:
31
AF XY:
AC XY:
3019
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
286
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 01, 2013 | - - |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2018 | - - |
Rubinstein-Taybi syndrome due to CREBBP mutations Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at